Lapatinib Tablet Ip 250mg

Lapatinib Tablet Ip 250mg Specification

Dosage Form
Oral

Life Span
24 months from manufacture

Origin of Medicine
India

Indication
HER2-positive breast cancer

Brand Name
Lapatinib Tablet IP 250mg

Salt Composition
Lapatinib Ditosylate

Packaging Type
Box

Pacakaging (Quantity Per Box)
30 tablets per box

Drug Type
Allopathic

Ingredients
Lapatinib

Physical Form
Tablet

Function
Anticancer medication, Tyrosine kinase inhibitor

Recommended For
Breast cancer patients

Dosage
As directed by physician

Dosage Guidelines
Take on an empty stomach or as prescribed

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store below 30C, Keep away from moisture and light

Caution
To be sold by retail on the prescription of an oncologist only

Expiry Date
As per packaging

Route of Administration
Oral

Prescription/Non-Prescription
Prescription only

Intended Use
Treatment of advanced or metastatic breast cancer

Marketed By
As per box

Strength
250 mg per tablet

Color
Yellow film-coated

Regulatory Status
Approved for pharmaceutical use

Shape
Oval

Side Effects
Diarrhea, rash, nausea, fatigue (consult physician for complete details)

Lapatinib Tablet Ip 250mg Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

About Lapatinib Tablet Ip 250mg

Packaging Size	150 Tablets
Brand	Herduo
Manufacturer	Natco
Form	Tablet
Strength	250 mg
Medicine Type	Allopathic
Packaging Type	Box

Lapatinib is used together with another medicine called capecitabine (Xeloda) or letrozole (Femara) to treat a certain types of advanced breast cancer that has spread to other parts of the body. Lapatinib 250mg from Herduo contains the active ingredient Lapatinib.

Targeted Breast Cancer Therapy

Lapatinib Tablet IP 250mg is designed for the treatment of advanced or metastatic breast cancer, especially in patients whose tumors are HER2-positive. This targeted therapy inhibits specific tyrosine kinases responsible for tumor growth, offering a focused approach with the benefit of improving patient outcomes. Consult your oncologist to determine if Lapatinib is suitable for your cancer management plan.

Proper Usage and Dosage Information

For optimal effectiveness, Lapatinib tablets should be administered on an empty stomach or as directed by your physician. Always follow the prescribed regimen and do not adjust your dosage without consulting your oncologist. Taking the medication according to the recommended schedule enhances its absorption and efficacy while reducing the risk of adverse effects.

Storage and Safety Precautions

Store Lapatinib Tablet IP 250mg in its original box below 30C, keeping it away from moisture and direct light. Do not use the medication beyond the expiry date indicated on the packaging. As this is a potent anticancer medication, it should be kept out of reach of children and handled according to your physician's instructions.

FAQ's of Lapatinib Tablet Ip 250mg:

Q: How does Lapatinib Tablet IP 250mg work in the treatment of breast cancer?

A: Lapatinib Tablet IP 250mg works by selectively inhibiting the HER2 and EGFR tyrosine kinases, proteins that are involved in the growth and survival of cancer cells. By blocking these signals, the medication helps stop the growth and spread of HER2-positive breast cancer cells.

Q: What is the recommended process for taking Lapatinib Tablet IP 250mg?

A: This medication should be taken orally, once daily, ideally on an empty stomach or as specifically instructed by your oncologist. Swallow the tablet whole with water, and avoid altering the prescribed dosage without medical consultation.

Q: When should this medicine be used?

A: Lapatinib Tablet IP 250mg is indicated for adults with advanced or metastatic breast cancer that is HER2-positive, as prescribed by an oncologist. It is typically used under medical supervision as part of a comprehensive cancer treatment plan.

Q: Where can I obtain Lapatinib Tablet IP 250mg?

A: This medicine is available by prescription only and should be obtained from a licensed pharmacy or hospital pharmacy, following the direction of a certified oncologist. Always check the packaging for the marketing authorization details.

Q: What important precautions should be taken while using this medication?

A: Store the tablets below 30C, away from moisture and direct light. Only use this medication under a physician's supervision, and promptly report any experienced side effects such as diarrhea, rash, nausea, or fatigue to your healthcare provider.

Q: What are the key benefits of using Lapatinib Tablet IP 250mg for breast cancer?

A: Lapatinib Tablet IP 250mg offers targeted action against HER2-positive breast cancer cells, potentially slowing cancer progression and improving clinical outcomes. Its use should always be prescribed and monitored by a qualified oncologist.

Q: How long can I store Lapatinib Tablet IP 250mg, and what is its shelf life?

A: The tablets have a shelf life of 24 months from the date of manufacture. Be sure to follow storage guidelines, and do not use the medication after the expiry date indicated on the packaging.